May 18, 2021
Chronic care management company DarioHealth scooped up digital mental health company wayForward for $30 million.
While DarioHealth got its start in diabetes management, it has quickly been expanding its chronic care coverage to include mental health, hypertension and other conditions.
As part of the acquisition, DarioHealth will be purchasing the creator of wayForward, PsyInnovations. The...
May 5, 2020
Pharma giant Johnson & Johnson is teaming up with Alevo Technologies on a new at-home diagnostic testing platform. The new tool, called the Alveo b.well, will be built to detect viral disease — which may one day include coronavirus detection. According to a release from the company, the product will include an analyzer, nasal swabs and cartridges for the detection of a virus. Consumers can...
January 16, 2020
The Digital Therapeutics Alliance, an industry group advocating for the adoption and understanding of evidence-based digital health treatments, has named its new Board of Directors. Representing handful of different digital therapeutics stakeholders, those named are set to hold their positions for a two-year period.
Along with Megan Coder, the group’s executive director, the board consists of:...
August 10, 2018
The second quarter of 2018 was a strong one for the rapidly expanding DarioHealth. Touting 70 percent year-over-year revenue growth and a continued decline in its cash burn rate, CEO Erez Raphael credited his company’s increasing fortune to recent US regulatory approvals and product launches as well as the company’s wider focus on an integrated consumer experience.
“Overall, we made an...
March 27, 2018
Israel-based DarioHealth has been granted 510(k) clearance for a version of its Blood Glucose Monitoring System that, alongside the Dario app, is compatible with iPhone 7, 8, and X, according to a statement from the company.
“We’ve been working tirelessly to bring forth a solution that would meet the rigorous standards required to achieve the FDA clearance,” DarioHealth CEO and Chairman Erez...
July 20, 2017
Global digital health outfit DarioHealth Corp., which emphasises mobile health and data solutions, has been granted Pre-market Notification (510(k)) clearance for the Dario app on certain Android mobile devices by the U.S. Food and Drug Administration.
Dario is a glucose meter that syncs with a companion app. The device, which is small enough to fit in someone’s pocket, consists of a glucose...